High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era (Q36500396)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 October 2012
edit
Language Label Description Also known as
English
High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era
scientific article published on 31 October 2012

    Statements

    High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit